Titan Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BSE:524717 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 Dec 25	Sell₹22,781	Ravinder Gupta	Individual	105	₹216.96
29 Sep 25	Sell₹3,746,839	Ravinder Gupta	Individual	20,000	₹187.34
26 Sep 25	Sell₹1,426,319	Ravinder Gupta	Individual	7,500	₹190.18
25 Sep 25	Sell₹466,935	Ravinder Gupta	Individual	2,500	₹186.77
19 Sep 25	Sell₹955,080	Ravinder Gupta	Individual	5,000	₹191.02
01 Sep 25	Sell₹715,203	Ravinder Gupta	Individual	4,500	₹158.93

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 524717?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	3,602,280	8.72%
State or Government	3,980,125	9.63%
Private Companies	6,722,275	16.3%
General Public	13,133,045	31.8%
Public Companies	13,880,775	33.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 13 shareholders own 68.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
33.6%	Titan Securities Limited	13,880,775	₹5.5b	0%	no data
9.63%	Investor Education and Protection Fund (IEPF)	3,980,125	₹1.6b	0%	no data
9.49%	Tanita Leasing & Finance Limited	3,922,275	₹1.6b	0%	no data
6.78%	Connoisseur Management Services Pvt Ltd	2,800,000	₹1.1b	0%	no data
2.8%	Manish Goel	1,157,810	₹461.0m	0%	no data
1.28%	Suresh Singla	528,355	₹210.4m	0%	no data
0.86%	Manju Singla	356,050	₹141.8m	0%	no data
0.8%	Madhu Gupta	332,550	₹132.4m	0%	no data
0.74%	Raja Singla	305,500	₹121.7m	0%	no data
0.66%	Supriya Singla	272,465	₹108.5m	0%	no data
0.61%	Udit Singla	250,000	₹99.6m	0%	no data
0.54%	Naresh Singla	222,550	₹88.6m	0%	no data
0.43%	Shivom Singla	177,000	₹70.5m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/12 11:38
End of Day Share Price	2026/08/12 00:00
Earnings	2026/03/31
Annual Earnings	2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Titan Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.